Biodistribution of ascorbyl palmitate loaded doxorubicin pegylated liposomes in solid tumor bearing mice

Journal of Microencapsulation

Volumn 28, Issue 2, 2011, Pages 142-149

  Jukanti, Raju ^a   Devraj, Gopinath ^a   Shashank, Apte S ^a   Devraj, Rambhau ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

ascorbyl palmitate; doxorubicin; ehrlich ascites; Liposomes; therapeutic availability

Indexed keywords

ASCORBYL PALMITATE; DOXORUBICIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG POTENCY; DRUG RELEASE; DRUG SOLUTION; DRUG TARGETING; EHRLICH ASCITES TUMOR; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; SERUM; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ASCORBIC ACID; CARCINOMA, EHRLICH TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MICE; POLYETHYLENE GLYCOLS;

EID: 79251604716     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.542496     Document Type: Article

References (35)

1. Allen TM. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev, 1994;13:285-309.
2. Allen TM, Hansen C, Martin F, Redemann C, Yau-young A. Liposomes containing synthetic lipid derivatives of poly (ethyleneglycol) show prolonged circulation in vivo. Biochim Biophys Acta, 1991;1066(1):29-36.
3. Arulsudar N, Subramanian N, Mishra P, Chuttani K, Sharma RK, Murthy RSR. Preparation, characterization, and biodistribution study of Technitium-99m- labeled leuprolide acetate-loaded liposomes in Ehrlich ascites tumor bearing mice. AAPS Pharm Sci, 2004;6(1):1-12.
4. Bahlis NJ, Grad JM, McMurry IJ, Neil J, Reis I, Dabaja MK, Eckman J, Goodman M, Femandez HF, Boise LH, et al. Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clin Cancer Res, 2002;8(12):3658-68.
5. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 1965;13:238-52.
6. Blume G, Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta, 1993;1146(2):157-68.
7. Brewster ME, Anderson W, Bodor N. Brain, blood and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits. J Pharm Sci, 1991;80:843-6.
8. Chiang CD, Song EJ, Yang VC, Chao CC. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung cancer cells. Biochem J, 1994;301(Pt 3):759):759-64.
9. D'Souza GGM, Wang T, Rockwell K, Torchilin VP. Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro. Pharm Res, 2008;25(11):2567-72.
10. Fulton AM, Chong YC. The role of macrophage derived TNFa in the induction of sublethal tumor cell DNA damage. Carcinogenesis, 1992;13:77-81.
11. Gabizon A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res, 1992;52:891-6.
12. Gabizon A, Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin: Rationale for use in solid tumours. Drugs, 1997;54(Suppl. 4):15):15-21.
13. Gaspar MM, Boerman CO, Laverman P, Corvo ML, Storm G, Cruz MEM. Enzymosomes with surface-exposed superoxide dismutase: In vivo behaviour and therapeutic activity in a model of adjuvant arthritis. J Control Release, 2007;117:186-95.
14. Gopinath D, Ravi D, Rao BR, Apte SS, Renuka D, Rambhau D. Ascorbyl palmitate vesicles (aspasomes): Formation, characterization and applications. Int J Pharm, 2004;271:95-113.
15. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol, 2000;156(4):1363-80.
16. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchillin VP, Jain RK. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA, 1998;95(8):4607-12.
17. Hong MS, Lim SJ, Oh YK, Kim CK. pH-sensitive, serum-stable and long circulating liposomes as a new drug delivery system. J Pharm Pharmacol, 2002;54:51-8.
18. Huang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res, 1992;52:5135-43.
19. Hunt CA, MacGregor RD, Siegel RA. Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations. Pharm Res, 1986;3:333-44.
20. Jain RK. Transport of macromolecules across tumor vasculature. Cancer Metastasis Rev, 1987;6:559-94.
21. Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Activity of amphipathic poly (ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta, 1991;1062:142-8.
22. Kundu N, Zhang S, Fulton AM. Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastasis of murine mammary carcinoma. Clin Exp Metastasis, 1995;13:16-22.
23. Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett, 1996;103(2):183-9.
24. Litzinger CD, Buiting MJA, Rooijen VN, Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly (ethylene glycol)-containing liposomes. Biochim Biophys Acta, 1994;1190:99-107.
25. Liu D, Mori A, Huang L. Role of liposome size and RES in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta, 1992;1104:95-101.
26. Lu W-L, Qi X-R, Zhang Q, Li R-Y, Wang G-L, Zhang R-J, Wei S-L. A pegylated liposomal platform: Pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug. J Pharmacol Sci, 2004;95:381-9.
27. Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst, 1989;6:193-210.
28. Mosqueira VCF, Legrand P, Morgat J, Vert M, Mysiakine E, Gref R, Devissaguet J, Barratt G. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: Effect of PEG chain length and density. Pharm Res, 2001;18:1411-19.
29. Notari RE. 1987. Pharmacokinetics biopharmaceutics and clinical pharmacokinetics - An introduction. 4th ed. New York: Marcel Dekker, pp. 45-128.
30. Oyen WJ, Boerman OC, Storm G, Van Bloois L, Koenders EB, Claessens RAMJ, Perenboom RM, Crommelin DJA, van der Meer JWM, Corstens FHM. Detecting infection and inflammation with technetium-99m labeled stealth liposomes. J Nucl Med, 1996;37(8):1392-7.
31. Papahadjopoulos D, Allen TM, Gabizon A. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA, 1991;88:11460-4.
32. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly (ethylene glycol)-coated vesicles. Biochim Biophys Acta, 1991;1062:77-82.
33. Uchiyama K, Nagayasu A, Yamagiwa Y, Nishida T, Harashima H, Kiwada H. Effects of the size and fluidity of liposomes on their accumulation in tumors: A presumption of their interaction with tumors. Int J Pharm, 1995;121:195-203.
34. Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res, 1995;55:4293-6.
35. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res, 1994;54:3352-6.